Commentary Open Access
Volume 2 | Issue 2 | DOI: https://doi.org/10.33696/cardiology.2.015
The Value of the Left Atrial Appendage Orifice Perimeter of 3D Model Based on 3D TEE Data in the Choice of Device Size of LAmbre™ Occluder
Dan Jia1, Qing Zhou1,*, Hong-Ning Song1, Lan Zhang1, Sheng Cao1, Bo Hu1, Jin-ling Chen1, Yu Liu2, Bin Kong2
- 1Department of Ultrasound Imaging, Renmin Hospital of Wuhan University, Wuhan, China
- 2Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China
Corresponding Author
Qing Zhou, qingzhou128@hotmail.com
Received Date: March 04, 2021
Accepted Date: July 21, 2021
Jia D, Zhou Q, Song HN, Zhang L, Cao S, Hu B, et al. The Value of the Left Atrial Appendage Orifice Perimeter of 3D Model Based on 3D TEE Data in the Choice of Device Size of LAmbre™ Occluder. J Clin Cardiol. 2021; 2(2):39-42.
Copyright: © 2021 Jia D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
The Value of the Left Atrial Appendage Orifice Perimeter of 3D Model Based on 3D TEE Data in the Choice of Device Size of LAmbre™ Occluder
Preoperative optimal selection of the occluder size is crucial in percutaneous left atrial appendage (LAA) occlusion, and the maximal width of the LAA orifice is the main reference index, however it cannot fully meet the practical operation requirements. We retrospectively analyzed three-dimensional (3D) transesophageal echocardiography (TEE) and computed tomography (CT) imaging dataset of the 41 patients who underwent LAA occlusion with LAmbre™ system.
Left Atrial Dysfunction in Patients with Coronary Slow Flow
In this review address the changes of LA structure and function in patients with CSFP according to our research and existing literature, therefore provide further insight into its clinical significance and pathophysiological mechanisms.
Commentary on: Echocardiography in Pulmonary Arterial Hypertension: Is It Time to Reconsider Its Prognostic Utility?
Pulmonary Arterial Hypertension (PAH) represents a rare but devastating disease due to small pulmonary arterial vessels remodelling and increased pulmonary vascular resistance leading to right ventricular dysfunction, right heart failure and death.
Left Atrial Appendage Occlusion: Where are We Going?
Prevention of ischemic stroke is one of the most important issues in patients with atrial fibrillation (AF). Currently, most patients are managed satisfactorily with oral anticoagulant (OAC) therapy. The remaining patients, who cannot tolerate long-term systemic OAC or who have an excess thrombotic burden that cannot be adequately controlled by OAC alone, require local anti-thrombotic therapy such as left atrial appendage (LAA) mechanical exclusion, either by surgical excision or percutaneous closure device implantation.